AP Healthcare Inc. (KOSDAQ:109960)
461.00
0.00 (0.00%)
Last updated: Apr 1, 2025
AP Healthcare Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Operating Revenue | 16,400 | 16,007 | 9,598 | 8,416 | 10,319 | Upgrade
|
Other Revenue | -0 | -0 | -0 | - | - | Upgrade
|
Revenue | 16,400 | 16,007 | 9,598 | 8,416 | 10,319 | Upgrade
|
Revenue Growth (YoY) | 2.46% | 66.77% | 14.04% | -18.44% | -52.89% | Upgrade
|
Cost of Revenue | 11,076 | 11,046 | 7,491 | 6,702 | 7,856 | Upgrade
|
Gross Profit | 5,324 | 4,960 | 2,107 | 1,714 | 2,462 | Upgrade
|
Selling, General & Admin | 3,456 | 3,800 | 2,880 | 4,041 | 4,011 | Upgrade
|
Research & Development | 782.82 | 794.25 | - | - | - | Upgrade
|
Other Operating Expenses | 52.02 | 59.78 | 59.11 | 86.79 | 269.54 | Upgrade
|
Operating Expenses | 4,807 | 25,964 | 6,168 | 4,294 | 2,838 | Upgrade
|
Operating Income | 517.32 | -21,004 | -4,061 | -2,579 | -375.22 | Upgrade
|
Interest Expense | -4,865 | -2,128 | -64.4 | -6.72 | -12.23 | Upgrade
|
Interest & Investment Income | 12,542 | 4,066 | 4,089 | 3,554 | 4,818 | Upgrade
|
Earnings From Equity Investments | - | - | 94.73 | 352.2 | -1,208 | Upgrade
|
Currency Exchange Gain (Loss) | 2.96 | 27.39 | -6.48 | 4.95 | -25.13 | Upgrade
|
Other Non Operating Income (Expenses) | -26,836 | -7,525 | 110.54 | 92.6 | 11.73 | Upgrade
|
EBT Excluding Unusual Items | -18,639 | -26,563 | 161.55 | 1,418 | 3,209 | Upgrade
|
Gain (Loss) on Sale of Investments | -7,705 | 32,157 | 2,628 | 1,332 | 4,415 | Upgrade
|
Gain (Loss) on Sale of Assets | 4.28 | 0.41 | -12.85 | -6.08 | 600 | Upgrade
|
Asset Writedown | - | -16.56 | - | -95.85 | - | Upgrade
|
Other Unusual Items | - | - | - | - | 0.79 | Upgrade
|
Pretax Income | -26,340 | 5,578 | 2,776 | 2,647 | 8,225 | Upgrade
|
Income Tax Expense | 1,680 | 1,406 | 345.83 | - | -2,835 | Upgrade
|
Earnings From Continuing Operations | -28,020 | 4,171 | 2,431 | 2,647 | 11,059 | Upgrade
|
Net Income to Company | -28,020 | 4,171 | 2,431 | 2,647 | 11,059 | Upgrade
|
Minority Interest in Earnings | -73.39 | 132.8 | - | 2.57 | 24.93 | Upgrade
|
Net Income | -28,094 | 4,304 | 2,431 | 2,650 | 11,084 | Upgrade
|
Net Income to Common | -28,094 | 4,304 | 2,431 | 2,650 | 11,084 | Upgrade
|
Net Income Growth | - | 77.09% | -8.28% | -76.09% | - | Upgrade
|
Shares Outstanding (Basic) | 114 | 54 | 36 | 36 | 36 | Upgrade
|
Shares Outstanding (Diluted) | 114 | 135 | 36 | 36 | 36 | Upgrade
|
Shares Change (YoY) | -15.09% | 276.69% | - | - | - | Upgrade
|
EPS (Basic) | -246.00 | 80.00 | 68.07 | 74.21 | 310.43 | Upgrade
|
EPS (Diluted) | -246.00 | 32.00 | 68.00 | 74.21 | 310.00 | Upgrade
|
EPS Growth | - | -52.94% | -8.37% | -76.06% | - | Upgrade
|
Free Cash Flow | 4,625 | 1,637 | 17,284 | -13,297 | 3,356 | Upgrade
|
Free Cash Flow Per Share | 40.50 | 12.17 | 484.06 | -372.40 | 93.99 | Upgrade
|
Gross Margin | 32.46% | 30.99% | 21.95% | 20.37% | 23.86% | Upgrade
|
Operating Margin | 3.15% | -131.22% | -42.32% | -30.65% | -3.64% | Upgrade
|
Profit Margin | -171.30% | 26.89% | 25.32% | 31.49% | 107.42% | Upgrade
|
Free Cash Flow Margin | 28.20% | 10.23% | 180.08% | -157.99% | 32.52% | Upgrade
|
EBITDA | 947.72 | -20,454 | -3,773 | -2,167 | 21.69 | Upgrade
|
EBITDA Margin | 5.78% | -127.78% | -39.31% | -25.75% | 0.21% | Upgrade
|
D&A For EBITDA | 430.4 | 549.54 | 288.85 | 412.57 | 396.91 | Upgrade
|
EBIT | 517.32 | -21,004 | -4,061 | -2,579 | -375.22 | Upgrade
|
EBIT Margin | 3.15% | -131.22% | -42.32% | -30.65% | -3.64% | Upgrade
|
Effective Tax Rate | - | 25.21% | 12.46% | - | - | Upgrade
|
Advertising Expenses | 16.36 | 18.38 | 21.49 | 780.34 | 208.58 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.